About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Fpr2tm1Rjf
targeted mutation 1, Roderick J Flower
MGI:4456271
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Fpr2tm1Rjf/Fpr2tm1Rjf involves: 129S/SvEv * C57BL/6 MGI:4456352


Genotype
MGI:4456352
hm1
Allelic
Composition
Fpr2tm1Rjf/Fpr2tm1Rjf
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fpr2tm1Rjf mutation (0 available); any Fpr2 mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• macrophages treated with formyl-Met-Leu-Phe (fMLP) or serum amyloid protein A (SAA) exhibit reduced chemotaxis compared with similarly treated wild-type cells
• the ability of AnxA1, dexamethasone, peptide Ac2-26, LXA4, and Cpd43 to inhibit polymorphonuclear accumulation into murine dorsal air pouches inflamed with IL1b is reduced compared to in similarly treated wild-type mice
• AnxA1 fails to inhibit polymorphonuclear accumulation in the peritoneal fluid of mice treated with zymosan unlike in wild-type mice
• SAA fails to increase the number of cells recruited by IL1b compared to in similarly treated wild-type mice
• the K/B x N serum provoked artherogenic response is exacerbated and prolonged compared to in similarly treated wild-type mice
• carrageenan induces a 2.5-fold increase in paw swelling with a larger number of infiltrating leukocyte compared to in similarly treated wild-type mice

homeostasis/metabolism
• following mesenteric ischemic-reperfusion injury, cell migration is increased compared to in similarly treated wild-type mice
• following mesenteric ischemic-reperfusion injury with longer reperfusion times, adherent and emigrated cells are increased compared to in similarly treated wild-type mice

skeleton
• the K/B x N serum provoked artherogenic response is exacerbated and prolonged compared to in similarly treated wild-type mice

cellular
• macrophages treated with formyl-Met-Leu-Phe (fMLP) or serum amyloid protein A (SAA) exhibit reduced chemotaxis compared with similarly treated wild-type cells

hematopoietic system
• macrophages treated with formyl-Met-Leu-Phe (fMLP) or serum amyloid protein A (SAA) exhibit reduced chemotaxis compared with similarly treated wild-type cells
• the ability of AnxA1, dexamethasone, peptide Ac2-26, LXA4, and Cpd43 to inhibit polymorphonuclear accumulation into murine dorsal air pouches inflamed with IL1b is reduced compared to in similarly treated wild-type mice
• AnxA1 fails to inhibit polymorphonuclear accumulation in the peritoneal fluid of mice treated with zymosan unlike in wild-type mice
• SAA fails to increase the number of cells recruited by IL1b compared to in similarly treated wild-type mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/14/2024
MGI 6.23
The Jackson Laboratory